Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Better quality of life reported after sentinel node biopsy
January 20th, 2005
Two studies from the multicenter ALMANAC trial presented at the 27th Annual San Antonio Breast Cancer Symposium have reported that sentinel lymph node biopsy results in significantly reduced arm morbidity and improved quality of life for breast cancer patients, compared with standard axillary lymph node dissection. The ALMANAC trial is a large, randomized, multicenter trial in the United Kingdom designed to quantitatively assess the effectiveness and morbidity of sentinel node biopsy in patients with clinically node-negative invasive breast cancer and compare it to standard axillary dissection. Standard axillary dissection has long been the standard...
Source: Women's Health Weekly (2005-01-20)
|
